BlueStar® Genomic Health Care Index
The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
Index Performance
Index performance of price, total return net and total return gross indexes is displayed in real-time.
| Period | Price | Total Return Net |
| Year-to-Date Performance | -29.06% | -29.05% |
| 1-Year Performance | -43.90% | -43.89% |
| 3-Year Performance | 5.59% | 5.66% |
| 5-Year Performance | 67.39% | 67.66% |
| Since Inception (31 Dec 2015) | 67.23% | 67.64% |
Index Records
Index highs and lows of price, total return net and total return gross indices are displayed in realtime.
| Period | Price | Total Return Net |
| All Time High/Low | 380.65 / 69.17 | 381.50 / 69.17 |
| 52-Weeks High/Low | 318.25 / 109.29 | 319.00 / 109.56 |
| Quarter High/Low | 167.23 / 128.02 | 167.64 / 128.34 |
| Month High/Low | 167.23 / 135.95 | 167.64 / 136.29 |
Index Correlation and Volatility
Index correlation to selected index peers and index volatility are updated daily.
| Index Volatility | |
| 1-month Volatility | 48.75 |
| 1-year Volatility | 45.17 |
Component Performance
Displayed are the best and worst index components over a selected period of time. Data is updated daily.
| Best 5 Components | 1-Year | Year-to-Date | 1-Day |
| ILLUMINA INC | -59.20% | -45.24% | -8.40% |
| Myriad Genetics Inc | -17.66% | 0.04% | 3.41% |
| REGENERON PHARMACEUTICALS | 3.41% | -0.44% | 0.77% |
| VERTEX PHARMACEUTICALS INC | 51.18% | 34.12% | 0.81% |
| ALNYLAM PHARMACEUTICALS INC | 16.39% | 37.90% | 1.94% |
| IONIS PHARMACEUTICALS INC | 12.19% | 44.92% | 1.52% |
| QIAGEN NV | -2.27% | -10.18% | 0.28% |
| EXACT SCIENCES CORP | -55.66% | -45.12% | 0.83% |
| SAREPTA THERAPEUTICS INC | 35.39% | 21.04% | -0.24% |
| GUARDANT HEALTH INC | -48.84% | -45.83% | 1.98% |
| MODERNA INC | -56.27% | -32.60% | -0.37% |
| PRECIGEN INC | -61.27% | -36.12% | 2.16% |
| AZENTA INC | -23.82% | -38.91% | 2.32% |
| BIONTECH SE | -56.71% | -37.19% | 1.11% |
| 10X GENOMICS INC | -70.08% | -67.62% | -0.17% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | -61.59% | -48.18% | 12.62% |
| ARROWHEAD PHARMACEUTICALS INC | -20.91% | -28.67% | 3.64% |
| BEAM THERAPEUTICS INC | -34.63% | -13.31% | 4.52% |
| BLUEPRINT MEDICINES CORP | -23.72% | -32.57% | 3.59% |
| CAREDX INC | -67.38% | -47.91% | 3.00% |
| Codexis Inc | -63.53% | -71.73% | 6.00% |
| CRISPR THERAPEUTICS AG | -41.90% | 3.80% | 1.55% |
| Editas Medicine, Inc. | -71.28% | -29.30% | 3.76% |
| Inovio Pharmaceuticals Inc | -72.86% | -47.29% | 6.91% |
| INTELLIA THERAPEUTICS INC | -57.74% | -42.71% | 3.26% |
| INVITAE CORP | -80.66% | -64.83% | 19.07% |
| Krystal Biotech, Inc. | 40.95% | 13.37% | 7.99% |
| MeiraGTx Holding plc | -20.89% | -52.61% | 7.24% |
| NanoString Technologies Inc | -70.27% | -59.79% | -2.08% |
| NATERA INC | -45.96% | -40.93% | 2.95% |
| NEOGENOMICS INC | -70.55% | -63.01% | 2.69% |
| Oxford BioMedica Plc | -67.98% | -63.41% | 1.34% |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | -71.27% | -57.04% | 10.71% |
| Pharming Group NV | -1.66% | 18.45% | -3.62% |
| PTC Therapeutics Inc | 31.97% | 32.44% | 1.42% |
| REGENXBIO Inc. | 6.24% | 2.05% | 0.75% |
| Rocket Pharmaceuticals, Inc | -43.28% | -19.97% | 6.33% |
| Sangamo Therapeutics, Inc | -38.00% | -15.60% | 8.76% |
| TWIST BIOSCIENCE CORP | -50.47% | -31.55% | 7.93% |
| UNIQURE N.V. | -30.44% | -1.74% | 3.50% |
| Veracyte Inc | -38.73% | -36.77% | 2.20% |
| ADAPTIVE BIOTECHNOLOGIES CORP | -62.19% | -56.09% | 1.65% |
| ALLOGENE THERAPEUTICS INC | -18.52% | 15.62% | 4.10% |
| ANGES INC | -61.48% | -22.85% | -0.84% |
| Fulgent Genetics, Inc. | -47.11% | -47.90% | 1.24% |
| GENSCRIPT BIOTECH CORP | -16.61% | -18.26% | -0.28% |
| SORRENTO THERAPEUTICS INC | -71.41% | -43.44% | 6.05% |
| ABCAM PLC | -23.20% | -33.38% | 2.35% |
| AMICUS THERAPEUTICS INC | 15.90% | 6.67% | 2.16% |
| Anavex Life Sciences Corporation | -39.54% | -32.81% | 6.01% |
| Avidity Biosciences Inc. | 10.58% | -7.66% | 15.40% |
| BioNano Genomics, Inc | -39.60% | 20.40% | 6.51% |
| Castle Biosciences Inc. | -49.08% | -20.83% | -0.79% |
| CUREVAC BV | -77.38% | -60.71% | 0.67% |
| DermTech, Inc. | -81.73% | -56.96% | 8.45% |
| Design Therapeutics, Inc | 49.40% | 16.25% | 8.08% |
| GALAPAGOS NV SPONSORED ADR | -7.85% | -1.60% | 0.15% |
| MARAVAI LIFESCIENCES HOLDINGS INC | -51.74% | -36.52% | -0.67% |
| Ocugen, Inc. | -64.37% | -37.58% | 5.97% |
| Pacific Edge Ltd | -61.15% | -63.26% | 1.76% |
| Praxis Precision Medicines, Inc. | -68.52% | -77.82% | 3.07% |
| Takara Bio | -43.84% | -32.62% | 0.29% |
| 23andMe Holding Co. Class A | -35.44% | -23.12% | 9.17% |
| 4D Molecular Therapeutics, Inc. | -65.81% | -56.52% | -8.27% |
| Absci Corp | -79.96% | -41.71% | -0.21% |
| Caribou Biosciences, Inc. | -57.34% | -34.33% | 5.54% |
| Carsgen Therapeutics Holdings Ltd- B | -43.34% | -35.18% | -1.25% |
| DICE Therapeutics, Inc. | 0.00% | -20.43% | -2.09% |
| Exscientia Plc ADR | 0.00% | -34.62% | 11.86% |
| GINKGO BIOWORKS HOLDINGS INC | -63.81% | -56.32% | 6.76% |
| Lyell Immunopharma, Inc. | -48.81% | -5.56% | 1.67% |
| OXFORD NANOPORE TECHNOLOGIES PLC | 0.00% | -59.63% | -6.66% |
| Sana Biotechnology, Inc. | -59.17% | -45.67% | 2.81% |
| Sema4 Holdings Corp. Class A | -79.12% | -45.52% | 11.98% |
| Tango Therapeutics, Inc. | -45.40% | -52.29% | 2.35% |
| Verve Therapeutics, Inc. | -40.77% | -3.47% | 5.33% |
| GreenLight Biosciences Holdings | -60.67% | -60.99% | -3.25% |
| Maxcyte Inc | -63.31% | -42.39% | 1.73% |
| Sirnaomics Ltd | 0.00% | -32.82% | -2.15% |
| Worst 5 Components | 1-Year | Year-to-Date | 1-Day |
| ILLUMINA INC | -59.20% | -45.24% | -8.40% |
| Myriad Genetics Inc | -17.66% | 0.04% | 3.41% |
| REGENERON PHARMACEUTICALS | 3.41% | -0.44% | 0.77% |
| VERTEX PHARMACEUTICALS INC | 51.18% | 34.12% | 0.81% |
| ALNYLAM PHARMACEUTICALS INC | 16.39% | 37.90% | 1.94% |
| IONIS PHARMACEUTICALS INC | 12.19% | 44.92% | 1.52% |
| QIAGEN NV | -2.27% | -10.18% | 0.28% |
| EXACT SCIENCES CORP | -55.66% | -45.12% | 0.83% |
| SAREPTA THERAPEUTICS INC | 35.39% | 21.04% | -0.24% |
| GUARDANT HEALTH INC | -48.84% | -45.83% | 1.98% |
| MODERNA INC | -56.27% | -32.60% | -0.37% |
| PRECIGEN INC | -61.27% | -36.12% | 2.16% |
| AZENTA INC | -23.82% | -38.91% | 2.32% |
| BIONTECH SE | -56.71% | -37.19% | 1.11% |
| 10X GENOMICS INC | -70.08% | -67.62% | -0.17% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | -61.59% | -48.18% | 12.62% |
| ARROWHEAD PHARMACEUTICALS INC | -20.91% | -28.67% | 3.64% |
| BEAM THERAPEUTICS INC | -34.63% | -13.31% | 4.52% |
| BLUEPRINT MEDICINES CORP | -23.72% | -32.57% | 3.59% |
| CAREDX INC | -67.38% | -47.91% | 3.00% |
| Codexis Inc | -63.53% | -71.73% | 6.00% |
| CRISPR THERAPEUTICS AG | -41.90% | 3.80% | 1.55% |
| Editas Medicine, Inc. | -71.28% | -29.30% | 3.76% |
| Inovio Pharmaceuticals Inc | -72.86% | -47.29% | 6.91% |
| INTELLIA THERAPEUTICS INC | -57.74% | -42.71% | 3.26% |
| INVITAE CORP | -80.66% | -64.83% | 19.07% |
| Krystal Biotech, Inc. | 40.95% | 13.37% | 7.99% |
| MeiraGTx Holding plc | -20.89% | -52.61% | 7.24% |
| NanoString Technologies Inc | -70.27% | -59.79% | -2.08% |
| NATERA INC | -45.96% | -40.93% | 2.95% |
| NEOGENOMICS INC | -70.55% | -63.01% | 2.69% |
| Oxford BioMedica Plc | -67.98% | -63.41% | 1.34% |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | -71.27% | -57.04% | 10.71% |
| Pharming Group NV | -1.66% | 18.45% | -3.62% |
| PTC Therapeutics Inc | 31.97% | 32.44% | 1.42% |
| REGENXBIO Inc. | 6.24% | 2.05% | 0.75% |
| Rocket Pharmaceuticals, Inc | -43.28% | -19.97% | 6.33% |
| Sangamo Therapeutics, Inc | -38.00% | -15.60% | 8.76% |
| TWIST BIOSCIENCE CORP | -50.47% | -31.55% | 7.93% |
| UNIQURE N.V. | -30.44% | -1.74% | 3.50% |
| Veracyte Inc | -38.73% | -36.77% | 2.20% |
| ADAPTIVE BIOTECHNOLOGIES CORP | -62.19% | -56.09% | 1.65% |
| ALLOGENE THERAPEUTICS INC | -18.52% | 15.62% | 4.10% |
| ANGES INC | -61.48% | -22.85% | -0.84% |
| Fulgent Genetics, Inc. | -47.11% | -47.90% | 1.24% |
| GENSCRIPT BIOTECH CORP | -16.61% | -18.26% | -0.28% |
| SORRENTO THERAPEUTICS INC | -71.41% | -43.44% | 6.05% |
| ABCAM PLC | -23.20% | -33.38% | 2.35% |
| AMICUS THERAPEUTICS INC | 15.90% | 6.67% | 2.16% |
| Anavex Life Sciences Corporation | -39.54% | -32.81% | 6.01% |
| Avidity Biosciences Inc. | 10.58% | -7.66% | 15.40% |
| BioNano Genomics, Inc | -39.60% | 20.40% | 6.51% |
| Castle Biosciences Inc. | -49.08% | -20.83% | -0.79% |
| CUREVAC BV | -77.38% | -60.71% | 0.67% |
| DermTech, Inc. | -81.73% | -56.96% | 8.45% |
| Design Therapeutics, Inc | 49.40% | 16.25% | 8.08% |
| GALAPAGOS NV SPONSORED ADR | -7.85% | -1.60% | 0.15% |
| MARAVAI LIFESCIENCES HOLDINGS INC | -51.74% | -36.52% | -0.67% |
| Ocugen, Inc. | -64.37% | -37.58% | 5.97% |
| Pacific Edge Ltd | -61.15% | -63.26% | 1.76% |
| Praxis Precision Medicines, Inc. | -68.52% | -77.82% | 3.07% |
| Takara Bio | -43.84% | -32.62% | 0.29% |
| 23andMe Holding Co. Class A | -35.44% | -23.12% | 9.17% |
| 4D Molecular Therapeutics, Inc. | -65.81% | -56.52% | -8.27% |
| Absci Corp | -79.96% | -41.71% | -0.21% |
| Caribou Biosciences, Inc. | -57.34% | -34.33% | 5.54% |
| Carsgen Therapeutics Holdings Ltd- B | -43.34% | -35.18% | -1.25% |
| DICE Therapeutics, Inc. | 0.00% | -20.43% | -2.09% |
| Exscientia Plc ADR | 0.00% | -34.62% | 11.86% |
| GINKGO BIOWORKS HOLDINGS INC | -63.81% | -56.32% | 6.76% |
| Lyell Immunopharma, Inc. | -48.81% | -5.56% | 1.67% |
| OXFORD NANOPORE TECHNOLOGIES PLC | 0.00% | -59.63% | -6.66% |
| Sana Biotechnology, Inc. | -59.17% | -45.67% | 2.81% |
| Sema4 Holdings Corp. Class A | -79.12% | -45.52% | 11.98% |
| Tango Therapeutics, Inc. | -45.40% | -52.29% | 2.35% |
| Verve Therapeutics, Inc. | -40.77% | -3.47% | 5.33% |
| GreenLight Biosciences Holdings | -60.67% | -60.99% | -3.25% |
| Maxcyte Inc | -63.31% | -42.39% | 1.73% |
| Sirnaomics Ltd | 0.00% | -32.82% | -2.15% |
